CRNX as of Nov 2 · 03:00 ET
CRNXNasdaqPharmaceutical Preparations

Crinetics Pharmaceuticals, Inc. · Brief

Next report

3 days

Nov 5 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±9.2%
avg realized
±6.3%
Feb 27 '25±11.0%▲+7.74%×0.70
May 8 '25±8.8%▼−6.18%×0.70
Aug 7 '25±10.4%▼−3.69%×0.35
Nov 6 '25±10.1%▼−8.02%×0.79
Jan 5 '26±10.1%▼−4.63%×0.46
Q1 FY26±12.4%▼−6.04%×0.49
May 7 '26±9.5%▼−13.82%×1.45
Q2 FY26±1.1%▲+0.12%×0.11
quarterimplied−15%0+15%realized×
Q2 FY26±1.1%▲+0.12%×0.11
May '26±9.5%▼−13.82%×1.45
Q1 FY26±12.4%▼−6.04%×0.49
Jan '26±10.1%▼−4.63%×0.46
Nov '25±10.1%▼−8.02%×0.79
Aug '25±10.4%▼−3.69%×0.35
2 older reports
May '25±8.8%▼−6.18%×0.70
Feb '25±11.0%▲+7.74%×0.70
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 4

3disclosed supplier and customer ties in sec filingsSEC filings
5tracked funds holding CRNXN-PORT · Aug 31 '26

Bear2 of 4

7 of 8recent reports where the move came in under the options implied rangeEarnings history
5 of 23largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

CRNX report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.